Unum Group (NYSE:UNM – Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 9.120-9.450 for the period, compared to the consensus EPS estimate of 9.100. The company issued revenue guidance of -.
Unum Group Stock Down 0.4 %
Shares of UNM stock traded down $0.32 on Tuesday, reaching $75.91. 1,257,534 shares of the stock were exchanged, compared to its average volume of 1,053,594. The company has a market capitalization of $13.86 billion, a price-to-earnings ratio of 8.21, a PEG ratio of 1.08 and a beta of 0.80. The business’s 50 day moving average price is $74.23 and its 200 day moving average price is $64.84. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a twelve month low of $46.64 and a twelve month high of $77.69.
Unum Group (NYSE:UNM – Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The financial services provider reported $2.03 EPS for the quarter, missing analysts’ consensus estimates of $2.14 by ($0.11). Unum Group had a net margin of 13.76% and a return on equity of 15.21%. As a group, sell-side analysts expect that Unum Group will post 8.54 earnings per share for the current fiscal year.
Unum Group Announces Dividend
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on UNM. Truist Financial boosted their price target on shares of Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, November 1st. Morgan Stanley upped their target price on Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 30th. BMO Capital Markets started coverage on Unum Group in a research note on Thursday, January 23rd. They issued an “outperform” rating and a $91.00 price objective for the company. Wells Fargo & Company raised their target price on shares of Unum Group from $74.00 to $81.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 14th. Finally, Barclays raised their price objective on shares of Unum Group from $76.00 to $85.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, Unum Group currently has an average rating of “Moderate Buy” and a consensus price target of $79.00.
View Our Latest Research Report on Unum Group
Insider Buying and Selling at Unum Group
In other news, CEO Richard P. Mckenney sold 58,865 shares of Unum Group stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $75.39, for a total transaction of $4,437,832.35. Following the completion of the transaction, the chief executive officer now owns 1,007,003 shares of the company’s stock, valued at $75,917,956.17. The trade was a 5.52 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total transaction of $769,200.00. Following the completion of the sale, the executive vice president now directly owns 54,827 shares in the company, valued at approximately $4,217,292.84. The trade was a 15.43 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 102,914 shares of company stock valued at $7,677,945. 0.93% of the stock is owned by company insiders.
About Unum Group
Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.
Read More
- Five stocks we like better than Unum Group
- What Are Earnings Reports?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How to Use the MarketBeat Excel Dividend Calculator
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Unum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unum Group and related companies with MarketBeat.com's FREE daily email newsletter.